CORONARY ARTERY CALCIUM IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA RECEIVING STANDARD LIPID-LOWERING THERAPY

被引：0
|
作者：
Sheth, Samip
Rader, Daniel
Jacoby, Douglas
机构：
来源：
CLINICAL CARDIOLOGY | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
113
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy
    Miname, Marcio H.
    Bittencourt, Marcio Sommer
    Moraes, Sergio R.
    Alves, Romulo I. M.
    Silva, Pamela R. S.
    Jannes, Cinthia E.
    Pereira, Alexandre C.
    Krieger, Jose E.
    Nasir, Khurram
    Santos, Raul D.
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (09) : 1797 - 1804
  • [2] Coronary Artery Calcium Score and Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia Patients Undergoing Standard Lipid Lowering Therapy
    Miname, Marcio
    Bittencourt, Marcio S.
    Moraes, Sergio R.
    Alves, Romulo, I
    Silva, Pamela R.
    Jannes, Cinthia E.
    Pereira, Alexandre C.
    Nasir, Khurram
    Santos, Raul D.
    CIRCULATION, 2018, 138
  • [3] ADHERENCE TO LIPID-LOWERING THERAPY IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V.
    Kuznetsova, T.
    ATHEROSCLEROSIS, 2018, 275 : E174 - E175
  • [4] Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy
    Galema-Boers, Annette M.
    Lenzen, Mattie J.
    Engelkes, Sophie R.
    Sijbrands, Eric J.
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 409 - 416
  • [5] ADHERENCE AND EFFICIENCY OF LIPID-LOWERING THERAPY IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN RUSSIA
    Ezhov, M. V.
    Tmoyan, N. A.
    Rozhkova, T. A.
    Duplyakov, D. V.
    Salchenko, V. A.
    Kachkovskii, M. A.
    Shaposhnik, I. I.
    Genkel, V. V.
    Gurevich, V. S.
    Urazgildeeva, S. A.
    Tregubov, A. V.
    Muzalevskaya, M. V.
    Bazhan, S. S.
    Timoshenko, O. V.
    Urvanceva, I. A.
    Kozhokar, K. G.
    Sokolov, A. A.
    Tishko, V. V.
    Boeva, O. I.
    Bolotova, E. V.
    Namitokov, A. M.
    Kushnareva, Y. B.
    Kuznetsova, T. Y.
    Korneva, V. A.
    Bogdanov, D. Y.
    Chichina, E. E.
    Soloviev, V. M.
    Ershova, A. I.
    Meshkov, A. N.
    Makogonenko, V. I.
    Galyavich, A. S.
    Sadykova, D. I.
    Pomogaybo, B. V.
    Barbarash, O. L.
    Kashtalap, V. V.
    Shutemova, E. A.
    Isaeva, I. G.
    Khokhlov, R. A.
    Oleynikov, V. E.
    Avdeeva, I. V.
    Chubykina, U. V.
    Bliznyuk, S. A.
    Alieva, A. S.
    Ovsyannikova, V. V.
    Furmenko, G. I.
    Chernykh, T. M.
    Abashina, O. E.
    Djanibekova, A. R.
    Slastnikova, E. S.
    Galimova, L. F.
    ATHEROSCLEROSIS, 2020, 315 : E43 - E43
  • [6] Lipid-lowering therapy for patients with or at risk of coronary artery disease
    Kjekshus, J
    Pedersen, TR
    Tobert, JA
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 418 - 427
  • [7] Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia
    Capra, Maria Elena
    Biasucci, Giacomo
    Banderali, Giuseppe
    Vania, Andrea
    Pederiva, Cristina
    CHILDREN-BASEL, 2024, 11 (02):
  • [8] Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia
    Ferrari, Filipe
    Martins, Vitor M.
    Rocha, Viviane Z.
    Santos, Raul D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (04) : 483 - 495
  • [9] EVALUATION OF LIPID-LOWERING THERAPY IN PATIENTS WITH DEFINITE DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN LODZ
    Gorzelak-Pabis, P.
    Pawlos, A.
    Staciwa, Z.
    Krulikowska, A.
    Broncel, M.
    ATHEROSCLEROSIS, 2022, 355 : E225 - E226
  • [10] THE LEVEL OF LIPOPROTEIN (A) A PREDICTOR OF SUBCLINICAL ATHEROSCLEROSIS IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA WHO ARE NOT RECEIVING LIPID-LOWERING THERAPY
    Galimova, L. F.
    Sadykova, D. I.
    Slastnikova, E. S.
    Usova, N. E.
    ATHEROSCLEROSIS, 2020, 315 : E143 - E143
12345